Sana Biotechnology SANA
$1.59 −$0.15 (-8.62%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $1.64 +3.06%
Open$1.70
Prev close$1.74
Day range$1.57 – $1.75
Volume4.46M
Market cap$476.42M
P/E (TTM)–
Dividend yield–
SANA Stock News
Headlines matching Sana Biotechnology or the SANA ticker, most recent first.
- H.C. Wainwright Remains a Buy on Sana Biotechnology (SANA)
- H.C. Wainwright Maintains Sana Biotechnology(SANA.US) With Buy Rating, Maintains Target Price $7
- Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)
- Morgan Stanley Maintains Sana Biotechnology(SANA.US) With Buy Rating, Maintains Target Price $12
- BofA Securities Maintains Sana Biotechnology(SANA.US) With Buy Rating, Cuts Target Price to $6 Negative
- TD Cowen Maintains Sana Biotechnology(SANA.US) With Buy Rating
- Wedbush Maintains Sana Biotechnology(SANA.US) With Buy Rating, Maintains Target Price $7
- 4: Sana Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Bilenker Joshua H.
- Sana Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Rosiello Robert L.
- Morgan Stanley Maintains Sana Biotechnology(SANA.US) With Buy Rating, Cuts Target Price to $3.07 Negative
- BofA Securities Maintains Sana Biotechnology(SANA.US) With Buy Rating, Maintains Target Price $7
- A Quick Look at Today's Ratings for Sana Biotechnology(SANA.US), With a Forecast Between $7 to $16
- Rodman & Renshaw Initiates Sana Biotechnology(SANA.US) With Buy Rating, Announces Target Price $16
- TD Cowen Maintains Sana Biotechnology(SANA.US) With Buy Rating, Announces Target Price $3.21
- Wedbush Maintains Sana Biotechnology(SANA.US) With Buy Rating, Raises Target Price to $7 Positive
No comments yet — be the first to weigh in on SANA.
Sign in to join the discussion.